Oncology

Session # A-109

The results are in: who is testing positive for NF1 on hereditary cancer multi-gene panels?

  • Cohort study of cases with pathogenic and likely pathogenic NF1 alterations identified on hereditary cancer multi-gene panels (MGPs).
  • Hereditary cancer MGPs are utilized for a subset of patients with a known clinical NF1 diagnosis without previous genetic testing (almost 50% of positive patients had previous clinical diagnosis).
  • Of patients without a previous clinical NF1 diagnosis, a small number ( 9.1%) reported at least one clinical feature of NF1 or specified no features of NF1 after physical evaluation (5.2%), and most did not comment on clinical history of NF1 features.
  • Patients without a clinical diagnosis of NF1 may also test positive for NF1 pathogenic alterations on hereditary cancer MGP testing and would benefit from further screening and genetic counseling.

Search Results

Start your search...